Skip to main content

Landry Robert E's Form 4 filing

Regeneron Pharmaceuticals, Inc. (REGN) · filed Aug 10, 2021

Accession no.
0001708138-21-000050
Filed
Aug 10, 2021
Trade date
Aug 6-10, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 20 non-derivative transactions and 2 derivative transactions. Open-market sales total $553.5K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Landry Robert ECIK 0001585160Officer (EVP Finance CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 6, 2021Common StockMOption exerciseAcquired+2,000$381.92+$763,84027,903Direct
Aug 6, 2021Common StockFTax withholdingDisposed−1,636$607.51−$993,886.3626,267Direct
Aug 9, 2021Common StockSSaleDisposed−1$610.85−$610.8526,266Direct
Aug 9, 2021Common StockSSaleDisposed−36$612.97F2−$22,066.9226,230Direct
Aug 9, 2021Common StockSSaleDisposed−1$613.79−$613.7926,229Direct
Aug 9, 2021Common StockSSaleDisposed−66$614.70F3−$40,570.226,163Direct
Aug 9, 2021Common StockSSaleDisposed−40$615.42F4−$24,616.826,123Direct
Aug 9, 2021Common StockSSaleDisposed−36$617.83F5−$22,241.8826,087Direct
Aug 9, 2021Common StockSSaleDisposed−58$618.44F6−$35,869.5226,029Direct
Aug 9, 2021Common StockSSaleDisposed−36$619.70F7−$22,309.225,993Direct
Aug 9, 2021Common StockSSaleDisposed−54$621.19F8−$33,544.2625,939Direct
Aug 9, 2021Common StockSSaleDisposed−36$623.54F9−$22,447.4425,903Direct
Aug 9, 2021Common StockMOption exerciseAcquired+3,000$381.92+$1,145,76028,903Direct
Aug 9, 2021Common StockFTax withholdingDisposed−2,463$617.68−$1,521,345.8426,440Direct
Aug 10, 2021Common StockSSaleDisposed−433$611.00−$264,56326,007Direct
Aug 10, 2021Common StockSSaleDisposed−50$612.31−$30,615.525,957Direct
Aug 10, 2021Common StockSSaleDisposed−1$614.09−$614.0925,956Direct
Aug 10, 2021Common StockSSaleDisposed−1$615.73−$615.7325,955Direct
Aug 10, 2021Common StockSSaleDisposed−45$618.89F10−$27,850.0525,910Direct
Aug 10, 2021Common StockSSaleDisposed−7$619.19F11−$4,334.3325,903Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 6, 2021Common StockMOption exerciseDisposed−2,000$0.00$022,565Direct
Aug 9, 2021Common StockMOption exerciseDisposed−3,000$0.00$019,565Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents volume-weighted average price of sales of 36 shares of Company stock on August 9, 2021 at prices ranging from $612.97 to $612.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents volume-weighted average price of sales of 66 shares of Company stock on August 9, 2021 at prices ranging from $614.34 to $614.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents volume-weighted average price of sales of 40 shares of Company stock on August 9, 2021 at prices ranging from $615.35 to $615.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents volume-weighted average price of sales of 36 shares of Company stock on August 9, 2021 at prices ranging from $617.73 to $617.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Represents volume-weighted average price of sales of 58 shares of Company stock on August 9, 2021 at prices ranging from $618.14 to $618.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Represents volume-weighted average price of sales of 36 shares of Company stock on August 9, 2021 at prices ranging from $619.48 to $619.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F8

Represents volume-weighted average price of sales of 54 shares of Company stock on August 9, 2021 at prices ranging from $621.02 to $621.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F9

Represents volume-weighted average price of sales of 36 shares of Company stock on August 9, 2021 at prices ranging from $623.40 to $623.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F10

Represents volume-weighted average price of sales of 45 shares of Company stock on August 10, 2021 at prices ranging from $618.13 to $618.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F11

Represents volume-weighted average price of sales of 7 shares of Company stock on August 10, 2021 at prices ranging from $619.16 to $619.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)